Objective: The research goal is to develop a wide-field retinal stimulating array for prosthetic vision. This study aimed to evaluate the efficacy of a suprachoroidal electrode array in evoking visual cortex activity after long term implantation.
Introduction
Visual prostheses have emerged as a viable treatment for blind patients who suffer retinal degenerative diseases [1] . Retinitis pigmentosa is one of the leading inherited causes of blindness in many countries and its symptoms include a progressive reduction of the visual field which increasingly impedes mobility [2] . Psychophysical studies have found that visual field size and contrast sensitivity correlate well with the level of orientation and mobility in retinitis pigmentosa (RP) patients [3, 4] . A therapeutic device aimed to assist with navigational tasks should provide a minimum visual field of 10-15˚ [5] . Electrical stimulation of the degenerated retina has been shown to be a feasible way of restoring visual perception [6] [7] [8] . Possible treatment alternatives also include gene therapy, stem cell therapy and retinal transplantation, but these have not translated into consistent clinical outcomes to date [9] . Clinical trials with retinal prostheses, however, have shown that blind patients can perceive some patterns and orientations [10] [11] [12] , and a prosthesis from Second Sight Medical Products Inc. has recently been approved by the US Food and Drug Administration.
Retinal prostheses have been successful at producing visual percepts in animal models and have been placed in several anatomical locations in the eye; i.e., epiretinal, subretinal, suprachoroidal, intrascleral and extraocular. Epiretinal and subretinal placement of electrode arrays have had the lowest thresholds for electrical stimulation of the retina [13] [14] [15] [16] and have been successful in clinical trials. However, implanting a wide visual prosthesis (more than 20˚ of visual field) using these approaches is challenging due to the limitations in implant size that can be placed subretinally [17] or due to mechanical instability associated with epiretinal implantation [18, 19] . In contrast, evaluation of extraocular stimulation demonstrated high thresholds with a wide area of retinal activation [6, 20] .
Suprachoroidal and intrascleral stimulation sites provide a good compromise with higher thresholds (compared to epiretinal and subretinal) [21] [22] [23] but punctate retinal activation [24] and access for safe surgical implantation of larger planar electrode arrays [25] .
Biocompatibility of suprachoroidal electrode arrays has been studied with promising results [26, 27] .
However, to date there has been no investigation on the effect of chronic implantation on the efficacy of retinal stimulation from the suprachoroidal space. We previously reported that a thin fibrous capsule and mild foreign body response formed around the suprachoroidal electrode array after 3 months of implantation [28] . The present study characterized the efficacy of a large-format suprachoroidal electrode array to evoke punctate activity in the visual cortex following 3 months of implantation. Further, this study assessed the effect of chronic implantation by comparing cortical responses between chronic and acute implantation. implanted with a suprachoroidal electrode array in the left eye. Six of these were implanted chronically. After 3 months of implantation, the animals were anesthetized for an electrophysiological experiment lasting 2 days. Four control animals underwent identical surgical implantation, followed immediately by acute electrophysiology where multi-unit activity was recorded.
Materials and Methods

Suprachoroidal electrode array
An electrode array was fabricated in a 19 mm × 8 mm biocompatible silicone substrate. The array consisted of 20 electrodes (plus 1 unconnected) made of platinum (Pt), spaced 1 mm from center to center. The array is shown in figure 1 . In a human eye, the visual field coverage would be approximately 9˚ × 20˚ [29] , while in the cat eye it was approximately 11˚ × 24˚ [30] . The electrodes were 600 µm in diameter to allow for an increase in total impedance with chronic implantation and because brightness matching at suprathreshold levels appears to be more efficient with relatively large electrodes [31] . The 1 mm electrode pitch was used because the minimum two point distance for perceptual discrimination was in the range of 0.6-1.7 mm for epiretinal studies [32] . Two return electrodes (Pt, ⌀ 2 mm) were placed within the substrate body. It has been established that there is no significant difference in monopolar stimulation thresholds with suprachoroidal versus vitreous return electrodes [33] [34] [35] , while suprachoroidal implantation has less associated risks. The implant substrate had a maximum thickness of 1 mm and minimum of 150 µm. This was built with layers of silicone sheet (Dow Corning) and silicone adhesive (MED-1137; Nusil). The top surface was contoured ( figure   1A ) to provide an anatomical fit and an even distribution of pressure onto the spherical sclera. Connector at the end of the cable made of Pt and silicone elastomer for chronic subdermal implantation.
There were 22 Pt-Ir (90-10%, ⌀ 25 µm; Sigmund Cohn) wires attached to the electrodes via spot welding and these were assembled into a helical cable lead. The cable traversed the sclera at one edge of the incision site. An episcleral patch made of silicone and reinforced with polyester mesh ( figure   1B ) was used to cover the trans-scleral exit point and provide fixation for the cable lead. A similar reinforced silicone patch was used to fix the cable to the orbital margin. The wires terminated in a biocompatible connector designed to be implanted subcutaneously ( figure 1C ). Baseline electrode total impedance was measured in normal saline prior to implantation. The electrode arrays were cleaned in consecutive baths of detergent (Pyroneg; JohnsonDiversey), ethanol, isopropanol, distilled water and then autoclaved at 121 °C for 30 min.
Surgical implantation
The cats were induced into anesthesia with a dose of xylazine (1 mg/kg, subcutaneous (s.c.); Xylazil;
Troy Labs, Australia) and ketamine (10 mg/kg, intramuscular (i.m.); Ketamil; Troy Labs) [36] . An endotracheal tube was inserted and anesthesia maintained with a continuous flow of isoflurane (Delvet, Australia) and oxygen during surgery. Heart rate, respiration rate, end-tidal CO 2 , blood pressure and core body temperature were monitored and anesthetic adjusted to maintain these within normal levels (170-220 beats per minute, 10-20 breaths per minute, 3-5 % CO 2 , 130/100 ̶ 160/120 mmHg and 36-38 °C). Paw withdrawal reflex was also tested to monitor appropriate anesthetic level.
Fluid replacement was provided by s.c. bolus of compound sodium lactate solution (2.5 ml/kg/hr;
Hartmann's; Baxter). For chronic implantation, the animal was given amoxicillin-clavulanate suspension once daily (10mg/kg, s.c; Clavulox; Pfizer, Italy) during the first week postoperative.
Topical applications of prednisolone (Prednefrin Forte; Australia), atropine (Atropt; Sigma Pharmaceuticals, Australia) and chloramphenicol (Chlorsig; Sigma Pharmaceuticals) were administered twice daily postoperatively and tapered off as required.
The surgical procedure was developed during acute studies with a thin film array [25] and refined to allow strong scleral closure for chronic implantation [28] . In brief, a full-depth scleral incision (9 mm 
Animal preparation for stimulation
At the end of the 3 month implantation period (chronic cohort), or following acute implantation (control cohort), the animals were prepared for a retinal stimulation and cortical recording experiment At the end of the experiment the animals were terminated with an overdose of sodium pentobarbital (150 mg/kg, i.v.; Pentobarbitone). After perfusion with neutral buffered formalin, the eyes were collected for histopathological assessment; these results were presented in a previous publication [28] .
Electrical stimulation
The retina was stimulated with the suprachoroidal electrodes using monopolar, constant-current, symmetric, biphasic pulses with a leading cathodic phase. Each phase was 500 µs in duration and there was an inter-phase delay of 25 µs. The stimuli were presented at a rate of 1.5 pulses per second which does not result in attenuation of the elicited response for repetitive retinal stimulation [37] . The charge injection density was kept below 180 µC/cm 2 , which is within the widely accepted non-gassing limits for Pt with wide pulses [38] . Electrodes were stimulated with a monopolar return configuration using one of the suprachoroidal return discs from the array. They were shorted to the return electrode after each stimulus pulse. The custom built stimulator had a compliance voltage of 24 V. The stimulator output was connected to the individual electrodes using an automated switching system [39] .
Impedance was calculated using the voltage transient [40] measured during the application of a monopolar constant current biphasic pulse to each electrode of 1 mA and 500 µs (figure 2) as has been described in [41] . Briefly, the voltage transient was defined to have an access voltage (Va) and a polarization voltage (Vp). These arise from the electrode-tissue interface's access resistance (Ra) and polarization impedance (Zp). Total impedance (Zt = Ra + Zp) was defined as the peak voltage in the leading cathodic phase divided by the measured current output (Zt = Vt / It). The baseline electrode impedance was measured initially in saline at room temperature. In vivo total impedance was then measured in chronically implanted animals, after 3 months of implantation, and in acutely implanted controls. 
Electrically evoked cortical recordings
A platinum ball macro-electrode (3 mm diameter) was placed on the dura over the visual cortex to record electrically evoked potentials (EEPs) in the six chronically implanted animals. The recording electrode was placed in the midline, between the posterior lateral gyri [42] . A platinum needle was placed in the neck as reference and an electrode in the thorax was used as a ground. Cortical potentials were recorded using a bioamplifier (ISO-80; World Precision Instruments) and an acquisition module (NI USB-6251; National Instruments). Recordings were performed in 2 independent consecutive sets of 50 averaged repetitions. Waveforms were filtered for a band-pass of 10-2000 Hz. The input-output function per retinal electrode was calculated using stimulus current levels ranging from 0 to 975 µA in steps of 75 µA, as shown in figure 3A . The current levels were presented in random order and analyzed using custom scripts in IgorPro software (Wavemetrics). EEP threshold [34] was considered as the minimum stimulus current level that yielded monotonically increasing peaks of at least 0.3 mV, within 30 ms of the stimulus (figure 3B). These peaks had to be aligned on the 2 sets of the stimulation function. The EEP waveforms were verified to contain the typical short-latency positive and shallow negative components corresponding to early electrically evoked activity, as has been described in previous publications [34, 43] . EEP recordings were not performed systematically in the acutely implanted control animals. To assess the effect of electrode location with respect to the retina, the outlines of the electrode arrays were obtained from fundus images of the chronically implanted animals. Figure 5A illustrates the approximate locations. The implant was typically placed beneath the superior retina where the lower corner of the implant was visible above the horizontal meridian (HM). Due to projection distortion in the fundus images, the implant locations were grouped categorically according to anatomical landmarks. The experiments were categorized in 3 groups according to the location of the lower corner relative to the HM (calculated in optic-disc diameters): I, implant corner inferior to HM; II, implant 1-2 disc diameters superior to the HM; III, implant more than 3 disc diameters superior to the HM. The electrode arrays had 7 rows of 3 electrodes. The analysis was therefore limited to vertical electrode location according to the electrode row position within the array, where the rows were numbered 1 to 7 starting from the bottom. An additive adjustment to the electrode row number was defined for each experiment (i.e. -4, -1, 2) to normalize the vertical location with respect to the horizontal meridian.
The arbitrary adjustment was related to the ratio of distance between electrode rows (0.87 mm) and the size of the optic disc (approximately 1 mm).
Multiunit activity cortical recordings
A 60 channel recording electrode array (Blackrock Microsystems, Foxborough, MA) was implanted in the visual cortex contralateral to the implanted eye to record evoked multiunit activity. The array was located 6 mm rostral from the inter-aural line and 1 mm lateral from the midline. Multiunit recordings were obtained from six chronically implanted animals and four acutely implanted controls. The needle-shaped recording electrodes had a platinum surface with a nominal impedance of ~400 kΩ at 1 kHz, in an array configuration of 6 × 10 electrodes with 400 µm pitch. These Utah intracortical microelectrode arrays are designed for recording in cortex [44] . The electrode arrays covered an area of 2 mm × 3.6 mm and penetrated into the cortex approximately 1 mm, chosen to target neurons in layer 4C. A Cerebus recording system (Blackrock Microsystems, Foxborough, MA, USA) was used to record multiunit activity with a sampling rate of 30 kHz. Input-output functions were calculated from stimulating the suprachoroidal electrodes with 10 stimulus pulses per level over a range of 0-975 µA, in 25 µA steps, presented in random order. Offline processing with custom scripts was used to identify spikes, as was published previously [45, 46] . Briefly, the stimulation artifact was suppressed and the spikes on the filtered signal (0.3-5 kHz Butterworth band-pass) that exceeded 4 times the root-meansquare of the signal, over a moving 60 s window, were counted within a window of 3-20 ms poststimulus onset (figure 4A).
To determine threshold and dynamic range, sigmoid curves were fitted to the spiking response to stimulus amplitude (figure 4B). The current level at 50% (P50) of the saturation spike count was defined to be the threshold, since it corresponded to the steepest slope in the response curve [36] . The dynamic range was calculated as the logarithmic ratio (dB) between the currents evoking 90% and 10% (P90 and P10) of the saturating neural activity. For each suprachoroidal electrode stimulated, only the cortical recording electrode with the best response (lowest P50 threshold) was used for analysis of threshold and dynamic range.
To quantify the selectivity of stimulation in the cortical response, the spiking activity across the recording array was expressed as a function of the distance to the recording electrode with the lowest threshold. A stimulation level of P90 (near saturation) of the recording electrode with the lowest threshold was chosen to calculate the spread of cortical activation. An exponential decay function was then fitted to this spatial response and the inverse decay constant 1/τ was used as a measure of cortical selectivity [45] . 
Statistical analyses
Minitab 16 was used for the statistical analyses. Results are presented at a double-tailed, 5%
significance level. Population distribution locations are represented with mean ± standard error (SE); or in the case of skewed distributions the median and 95% confidence interval (CI) for the median are given. Pearson correlation was used for testing associations. Total impedance data were compared using paired T-tests where pairing was individual electrodes. Variability of the total impedance distributions was tested using F tests for equal variances. Effect of electrode location on the EEP threshold distribution was tested with non-parametric analysis using a Kruskal-Wallis test.
Distributions of multi-unit activity data were compared with Student's t-test.
Results
The implant was stable in all chronically implanted animals and there was a thin fibrous tissue capsule on the electrode array surface [28] . 
Electrode Impedances
The average total electrode impedance measured in vivo after 3 months of implantation was 12.5 ± 0.3 kΩ (mean ± SE). The in vivo total electrode impedance was higher than the baseline measured in saline before implantation of 3.13 ± 0.04 kΩ (paired T-test: T = -31.4, P < 0.001). The increase in total impedance for each electrode from baseline to in vivo was higher for chronically implanted electrodes (Z t in vivo / Z t baseline = 416 %) than for acute controls (322 %) (T-test: T = -7.16, P < 0.001).
Impedance measurements were repeated on the second day of the electrophysiology experiment, after the electrodes had been repeatedly stimulated. The mean total impedance after stimulation was 10.8 ± 0.2 kΩ, which was 13 % lower than the initial in vivo total impedance (paired T-test: T = 13.6, P < 0.001). The range of in vivo total electrode impedance that includes 90% of the electrodes was 7.2-15.8 kΩ (5 th -95 th percentile). Using monopolar stimulation, EEPs were successfully recorded for 98 out of the 100 electrodes tested, within the charge density limit of 180 µC/cm 2 . The mean EEP threshold was 189 ± 9. The effect of threshold with respect to electrode locations on the retina was assessed. From the approximate implant locations in figure 5A , an additive adjustment to the electrode row number was defined for each experiment (table 2) to normalize the location with respect to the horizontal meridian.
Electrically evoked cortical potentials
With the adjustment, an approximate coverage of 13 electrode rows (about 48˚ of visual field) was estimated across animals. Figure 5 shows the EEP thresholds per adjusted row across all experiments.
There was a marked variation of the EEP threshold with the electrode location where the lower thresholds were in the central rows (central 7 rows vs. 6 peripheral rows, Mann-Whitney: W = 2315, P < 0.0001). 
Multiunit activity
From recordings of multiunit activity in the visual cortex, following electrical stimulation of the chronically implanted suprachoroidal electrodes, a P50 threshold was successfully obtained, in at least one cortical site, for 35 stimulated electrodes. These successful recordings were obtained with 4 animals (subjects C4, C5, C7 and C8). The mean stimulation charge for the P50 threshold was 181 ± 14 nC/phase, corresponding to a charge density of 64 ± 5 µC/cm 2 , using the best cortical site per electrode (that which needed the least current to reach the 50% threshold). Recordings were not attempted in one animal (C3) and were unsuccessful in another (C6) likely due to change in recording site (anteriorly) because of cortical vasculature.
These multi-unit activity recordings in chronically implanted animals were compared to those from the acutely implanted control animals. There were 45 electrodes in these acutely implanted control animals for which a P50 threshold could be determined from cortical recordings. Figure 6A and figure   6B show that the mean threshold from the acutely implanted control electrodes was 80% higher than the chronically implanted ones (Student's t-test: T = 5.74, P < 0.001). However, the dynamic range (difference between P10 and P90 in a decibel scale) was not found to be different between chronic and acute electrodes as shown in figure 6C . The selectivity in cortical activation from electrical stimulation was not found to be different between chronic and acutely implanted electrodes ( figure 6D ). Bars represent mean and error bars are standard error. Stars represent statistically significant difference (t-test P < 0.001).
Discussion
The chronically-implanted suprachoroidal electrode array reliably evoked responses in the visual cortex with monopolar stimulation of single electrodes in 98 of 100 stimulated electrodes, well within safe electrochemical gassing limits for platinum. The electrode array and helical lead-wire [47] showed reasonable durability (10 of 103 electrodes failed) after 3 months of implantation. Electrode arrays implanted in the suprachoroidal space have been found to be safe, mechanically stable [28] and to elicit cortical activity following acute implantation [34, 48, 49] . EEP thresholds reported from acute implantation are in the range of 26-200 nC [21, 22, 24, 34, 49] which is one order of magnitude higher than those for subretinal or epiretinal stimulation [14, 15, 21, 50] . This study is the first systematic report of thresholds from single electrode stimulation in chronically implanted suprachoroidal arrays.
Comparison of multiunit activity between chronic and acute suprachoroidal implantation indicated a reduced threshold after chronic implantation, but no change in the dynamic range of stimulation. This suggests that chronic implantation of the electrode array has not damaged the neural targets for the stimulation. The higher thresholds found in acute implantation were presumably associated with an increase in distance between the electrode and the retina as a result of acute bleeding and edema [25] .
This contrasts with the thin fibrous tissue encapsulation observed after 3 months of implantation [28] .
The stimulation thresholds in this study do not greatly differ from those reported previously for acute suprachoroidal or intrascleral implantation [22, 34] . Importantly, the charge required to reach threshold is well within the traditionally accepted safe electrochemical injection limits for platinum electrodes [38, 51] . The selectivity in cortical activation from electrical stimulation was not found to be different between chronic and acutely implanted electrodes (figure 6D); but it was wider than the cortical selectivity reported previously with stimulation of 400 µm diameter electrodes [45] . This implies that the electric fields of the stimuli are reasonably localized on the retina and the fibrous tissue encapsulation does not have a substantial effect. Regarding stimulation-induced neural injury [52] , further evaluation is required using long term supra-threshold stimuli to assess the safety of electrical stimulation on the retina.
The EEPs observed in the visual cortex indicated that the retinal stimulation was to some extent localized ( figure 5 ). The thresholds seemed to correspond with the vertical location on the retina and the electrodes near the horizontal meridian had the lowest thresholds. This could be explained by variation of the visual field mapping of the cortical recording electrode and the exponential decrease in ganglion cell density with eccentricity [53] . The thresholds near area centralis and the similarities with those in acute implantation [34] suggest that the chronic tissue reaction did not effect the efficacy of neural stimulation.
The observed short latency of the EEP and early spikes in the multi-unit responses are thought to relate to the direct response of retinal ganglion cells to electrical stimulation [43] , since the responses of the outer retinal and bipolar cells typically have longer latencies [54] . A similar oscillatory response to the one observed early on the rise of the positive peaks, has been previously described from in vitro studies as nerve fiber activity and reverberation in the inner plexiform layer due to simultaneous excitatory and inhibitory inputs to the ganglion cells [55, 56] .
The high in vivo electrode impedance, measured following 3 months of implantation, is linked with the good biocompatibility exhibited by the implant [28] . Tight fibroblast layers result in higher impedance than loose fibroblast layers and ongoing inflammation resulting from a foreign body reaction [57, 58] . The 3 month implantation period was considered sufficient to reach a steady scar response in the eye [59] . The drop in electrode impedance observed after electrical stimulation has been reported previously and is likely related to localized changes in the tissue adjacent to the electrode [41] . However, the relatively high total impedances indicate that relatively large surface area electrodes are required to reduce stimulator voltage requirements.
Epiretinal and subretinal implantation have been successful in clinical trials [10, 60, 61] . These devices are positioned closer to the target neural elements and have been expected to have a greater likelihood of eliciting high-acuity perception. However, addressing a large visual field can be challenging with epiretinal and subretinal techniques due to device size restrictions. The present efficacy results, combined with the simplicity of the suprachoroidal surgery [28] , indicate that this approach is capable of providing effective stimulation over a range of more than 40˚ of visual field ( figure 5A ). As such, suprachoroidal arrays are a promising alternative for use in a safe, wide-field prosthesis, which is expected to be a useful mobility aid for late-stage RP patients.
